ANAM RAHIM: Open Payments
NPI 1831678788 · INDEPENDENCE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$652 in 31 payments from 15 companies in 2025. Trend: 2023 $119 · 2024 $899 · 2025 $652
Food & beverage: $652
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $106 |
| Merck Sharp & Dohme LLC | 3 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $72 |
| GlaxoSmithKline, LLC. | 2 | $56 |
| Electromed, Inc. | 4 | $51 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
| Tandem Diabetes Care, Inc. | 3 | $48 |
| Lilly USA, LLC | 2 | $33 |
| Insmed, Inc. | 1 | $32 |
| Dexcom, Inc. | 1 | $28 |
Products named: DUPIXENT, ZERBAXA, SMARTVEST, t:slim X2 Insulin Pump with Control-IQ, OFEV, MOUNJARO, Arikayce, TRELEGY ELLIPTA.
Industry payments across MO — which companies pay providers there.
